Overview
This page compares Injective and CFX with live PEPS metrics. Rankings (#99 vs #149) and liquidity profiles differ, so traders often use them for distinct roles rather than as perfect substitutes.
Quick winners
Full comparison
| Metric | INJ | CFX |
|---|---|---|
| Price | $5.00 | $0.042290 |
| Market Cap | $490.41M | $220.81M |
| FDV | — | — |
| Volume 24h | $2.50M | $1.25M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 149.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | CFX |
|---|---|---|
| 1H | — | — |
| 24H | +1.77% | -1.03% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | CFX |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.07 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 65.00 |
| Signal | neutral | neutral |
Automatic technical analysis
When RSI and trend disagree across Injective and CFX, expect choppy relative performance until one side reclaims a clear structure.
Fundamentals
| Metric | INJ | CFX |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
CFX
Pros and cons
Pros of Injective
- INJ often anchors narratives that attract sustained media and analyst coverage.
- Market-cap scale on Injective may dampen some idiosyncratic shocks versus smaller peers.
- Injective has an established coin page footprint on PEPS for continuous monitoring.
Cons of Injective
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Indicator stacks on Injective may stay stretched longer than expected in strong trends.
- Large-cap status for Injective can mean slower percentage upside versus high-beta alternatives.
Pros of CFX
- CFX can offer higher relative beta when market attention rotates toward its niche.
- Diversifying versus Injective with CFX can change portfolio factor exposure.
- PEPS tracking for CFX still includes AI score and level context for monitoring.
Cons of CFX
- Relative underperformance versus Injective can persist through entire market regimes.
- Higher volatility on CFX cuts both ways and demands stricter risk limits.
- Weaker market-cap standing may leave CFX more exposed to liquidity droughts.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
Which looks stronger right now?
The “stronger” label here is descriptive, not predictive. Injective and CFX can alternate leadership as macro liquidity and narrative rotate.
AI summary
Comparing INJ and CFX begins with structure: capitalization, volume and rank. Present prints are $5.00 versus $0.042290. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate CFX-vs-INJ pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, Injective or CFX?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or CFX?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and CFX.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.